Presented on September 9th, 2023.

Moderator: Tom Cooper, MD
Baylor College of Medicine, Houston, Texas, United States 

Experience rapid-fire talks in our Lightning Round featuring top poster submissions on myotonic dystrophy. Predoctoral, postdoctoral, and early career scholars present their groundbreaking research, showcasing the most promising findings. Witness the future of myotonic dystrophy research condensed into concise, dynamic talks. Engage with rising stars in the field and gain valuable insights. Click here to download the 2023 DM Research Poster Abstracts.

Click here to learn more about the 2023 MDF Annual Conference.

Lightning Round Speakers:

• REACH DM1- Remote assessments and genetic analysis in patients with Myotonic Dystrophy Type 1 (Poster ID # 45)
  Johanna Hamel, MD 
  University of Rochester Medical Center, Department of Neurology, Rochester, New York, United States
   
• The role of MBNL in smooth muscle function and DM1 gastrointestinal pathologies (Poster ID # 13)
  Janel Peterson 
  Department of Pathology & Immunology, Baylor College of Medicine, Houston, Texas, United States
   
• Individual transcriptomic response to strength training for patients with myotonic dystrophy type 1 (Poster ID # 29)
  Claudia Lennon  
  The RNA Institute, College of Arts and Sciences, State University of New York at Albany, New York, United States
   
• Supervised strength training in women with myotonic dystrophy type 1 (Poster ID # 40)
  Laura Girard-Côté 
  Université du Québec à Chicoutimi (UQAC), Saguenay, Québec, Canada, Interdisciplinary Research Group on Neuromuscular Disorders, Centre intégré universitaire de santé et de services sociaux du Saguenay-Lac-St-Jean, Jonquière, Canada 
   
• Extracellular RNA splice events in cerebrospinal fluid as candidate biomarkers of myotonic dystrophy type 1 (Poster ID # 39)
  Preeti Kumari, PhD 
  Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States 
   
• Investigating global and cell type-specific transcriptomic dysregulation in the DM1 brain (Poster ID # 43)
  Emily Davey  
  Department of Molecular Genetics & Microbiology, Center for NeuroGenetics, Genetics Institute, University of Florida, Gainesville, Florida, United States 
   
• Choroid plexus mis-splicing and altered cerebrospinal fluid composition in myotonic dystrophy type 1 (Poster ID # 23)
  Curtis Nutter, PhD 
  Department of Molecular Genetics and Microbiology, Center for NeuroGenetics and the Genetics Institute, University of Florida, Gainesville, Florida, United States  
   
• Quercetin selectively reduces expanded repeat RNA levels in models of myotonic dystrophy (Poster ID # 34)
  Subodh Mishra, PhD 
  The RNA Institute, State University of New York at Albany, New York, United States 
   
• Benefit of amlodipine or ranolazine on myotonic dystrophy bi-channelopathy (Poster ID # 21)
  Lily Cisco 
  University of Rochester, New York, United States